The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort
Open accessAbstract
Transcranial Doppler (TCD) is used to detect children with sickle cell anemia (SCA) who are at risk for stroke, and transfusion programs significantly reduce stroke risk in patients with abnormal TCD. We describe the predictive factors and outcomes of cerebral vasculopathy in the Créteil newborn SCA cohort (n = 217 SS/Sβ0), who were early and yearly screened with TCD since 1992. Magnetic resonance imaging/magnetic resonance angiography was performed every 2 years after age 5 (or earlier in case of abnormal TCD). A transfusion program was recommended to patients with abnormal TCD and/or stenoses, hydroxyurea to symptomatic patients in absence of macrovasculopathy, and stem cell transplantation to those with human leukocyte antigen-genoidentical donor. Mean follow-up was 7.7 years (1609 patient-years). The cumulative risks by age 18 years were 1.9% (95% confidence interval [95% CI] 0.6%-5.9%) for overt stroke, 29.6% (95% CI 22.8%-38%) for abnormal TCD, which reached a plateau at age 9, whereas they were 22.6% (95% CI 15.0%-33.2%) for stenosis and 37.1% (95% CI 26.3%-50.7%) for silent stroke by age 14. Cumulating all events (stroke, abnormal TCD, stenoses, silent strokes), the cerebral risk by age 14 was 49.9% (95% CI 40.5%-59.3%); the independent predictive factors for cerebral risk were baseline reticulocytes count (hazard ratio 1.003/L × 109/L increase, 95% CI 1.000-1.006; P = .04) and lactate dehydrogenase level (hazard ratio 2.78/1 IU/mL increase, 95% CI1.33-5.81; P = .007). Thus, early TCD screening and intensification therapy allowed the reduction of stroke-risk by age 18 from the previously reported 11% to 1.9%. In contrast, the 50% cumulative cerebral risk suggests the need for more preventive intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“small-vessel lesions are the most common cerebrovascular lesions in SCD, with a prevalence of 13% at 14 months of age (163) that progressively rises throughout childhood (164) such that, by adulthood, it is approximately 50% (165, 166).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [164]
Citations
Cites
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866 · cited 1×
“The LIC was greater than normal ( 36 mol/gdw) in 23 patients and the median (range) LIC was 220 mol/gdw (5-529), but none of the patients had cardiac T2* 20 milliseconds.”
BackgroundCerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia
Gaston, M. H., Verter, J. I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142501 · Cited by 1,162
Improved survival of children and adolescents with sickle cell disease
Quinn, C. T., Rogers, Z. R., McCavit, T. L., & Buchanan, G. R. (2010) · Blood · doi:10.1182/blood-2009-07-233700 · Cited by 907
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., & Hess, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260905 · Cited by 658
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa050460 · Cited by 635
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Bernaudin, F., Socie, G., Kuentz, M., Chevret, S., Duval, M., Bertrand, Y., Vannier, J.-P., Yakouben, K., Thuret, I., Bordigoni, P., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079665 · Cited by 515
Self-citationPrediction of Adverse Outcomes in Children with Sickle Cell Disease
Miller, S. T., Sleeper, L. A., Pegelow, C. H., Enos, L. E., Wang, W. C., Weiner, S. J., Wethers, D. L., Smith, J., & Kinney, T. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420203 · Cited by 508 · cited 1×
“The LIC was greater than normal ( 36 mol/gdw) in 23 patients and the median (range) LIC was 220 mol/gdw (5-529), but none of the patients had cardiac T2* 20 milliseconds.”
Background
Research works printed but not linked: 3
- Bernaudin, 2001, Early cerebral exploration with transcranial Doppler (TCD) in patients with sickle cell disease: effects of age and risk factors on velocities [abstract]., Blood, 98, 784a
- Bernaudin, 1999, Hydroxyurea (HU) therapy improves cognitive functioning in sickle cell disease (SCD) patients [abstract]., Blood, 94
- Arnaud, 2008, Comparaison de l'efficacité et du coût de l'Hydréa, du programme transfusionnel et de la greffe de cellules souches sur 76 enfants drépanocytaires avec fréquentes crises vaso-occlusives et ou syndromes thoraciques., Hématologie, 14, 31
Cited by
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)
Zhao, Y., Zhang, X., Chen, X., & Wei, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5070 · Cited by 634
Controlled Trial of Transfusions for Silent Cerebral Infarcts in Sickle Cell Anemia
DeBaun, M. R., Gordon, M., McKinstry, R. C., Noetzel, M. J., White, D. A., Sarnaik, S. A., Meier, E. R., Howard, T. H., Majumdar, S., Inusa, B. P. D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401731 · Cited by 545
Self-citationWare, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01041-7 · Cited by 515
Metadata
- Authors
- Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galactéros, F., Torres, M., Kuentz, M., Ferry, C., Socié, G., Reinert, P., & Delacourt, C.
- Affiliations
- Hôpital Saint-Louis (FR)
- Hôpital Intercommunal de Créteil (FR)
- Pediatrics, Referral Center for Sickle Cell Disease, Centre Hospitalier Intercommunal, Créteil, France;
- Biochemistry, Henri Mondor Hospital, Créteil, France;
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Pediatrics, University of Southern California, Los Angeles, Los Angeles, California; and
- Hematology, Saint-Louis Hospital, Paris, France;
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-01-27
- Volume
- 117
- Issue
- 4
- Pages
- 1130-1140
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1978242664
- Cited by
- 336
- References
- 49
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 14 · 2023: 17 · 2022: 23 · 2021: 26 · 2020: 23 · 2019: 20 · 2018: 21 · 2017: 29 · 2016: 37 · 2015: 20 · 2014: 26 · 2013: 27 · 2012: 23
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- sickle cell disease, transcranial Doppler screening, cerebral vasculopathy, stroke risk, cerebral stenosis, silent stroke, hydroxyurea, transfusion therapy, stem cell transplantation, reticulocyte count, lactate dehydrogenase, predictive factors, macroangiopathy, magnetic resonance angiography
- MeSH terms
- Anemia, Sickle Cell, Cerebral Arterial Diseases, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Infant, Newborn, Diseases, Male, Time Factors, Cohort Studies, Neonatal Screening, Treatment Outcome, Ultrasonography, Doppler, Transcranial, Magnetic Resonance Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. https://app.cochat.ai/papers/10.1182/blood-2010-06-293514
- The paper
- Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., Abadie, I., Medejel, N., Madhi, F., Lemerle, S., Biscardi, S., Bardakdjian, J., Galactéros, F., Torres, M., Kuentz, M., . . . Delacourt, C. (2011). Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. https://doi.org/10.1182/blood-2010-06-293514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.